Er. Myers et al., COST-EFFECTIVENESS OF MANDATORY COMPARED WITH VOLUNTARY SCREENING FORHUMAN-IMMUNODEFICIENCY-VIRUS IN PREGNANCY, Obstetrics and gynecology, 91(2), 1998, pp. 174-181
Objective: To determine the cost-effectiveness of mandatory screening
for human immunodeficiency virus (HIV) in pregnancy compared with that
of voluntary screening under varying assumptions about patient behavi
or. Methods: Using a health care system perspective, a decision-analys
is model was constructed to estimate the outcomes and costs of the two
strategies. Average and incremental cost-effectiveness ratios were ca
lculated for each strategy. Sensitivity analyses were performed to tes
t the effects of different values on the results of the simulation. In
particular, we examined the potential effects of changes in patient b
ehavior resulting from mandatory screening on our estimates of cost-ef
fectiveness. Results: At a prevalence of 170 per 100,000, average cost
s per case prevented were $255,158 and $367,998 for mandatory and volu
ntary screening, respectively. The incremental cost-effectiveness of m
andatory compared with voluntary screening was $29,478. These values d
ecreased as prevalence of HIV increased, or as the estimated lifetime
cost of pediatric HIV infection increased: above an estimated cost for
pediatric HIV of $129,250, mandatory screening was less expensive and
more effective than voluntary screening. Assumptions about patient be
havior affected these results: a 40% reduction in zidovudine acceptanc
e in women identified only through mandatory screening increased the i
ncremental cost-effectiveness to $112,434. The impact of behavior incr
eased as the prevalence of HIV increased. Conclusion: Mandatory screen
ing will prevent more cases of pediatric AIDS, but at a somewhat highe
r cost than voluntary screening under baseline assumptions. The cost-e
ffectiveness of mandatory screening will be influenced by patient beha
vior, especially acceptance of zidovudine treatment among women who wo
uld have refused voluntary screening. (C) 1998 by The American College
of Obstetricians and Gynecologists.